Clinical Trial Update: A Study to Observe Vedolizumab and Anti-tumour Necrosis Factors (Anti-TNFs) Outcomes in Real-world Biologic Ulcerative Colitis (UC) and Crohn's Disease (CD) Participants

View source ↗

Summary

A completed real-world observational study evaluating vedolizumab and anti-TNF therapies in patients with ulcerative colitis or Crohn's disease; results have be…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease
• Ulcerative Colitis

Drugs mentioned

• Vedolizumab (vedolizumab)
• anti-TNF-α agents (anti-TNF-α therapy)

Snippet

Sponsor: Takeda | Conditions: Colitis, Ulcerative, Crohn Disease | Status: COMPLETED | Results posted: 2024-05-30